התחל במצב לא מקוון עם האפליקציה Player FM !
Episode #50: Exploring Prostate Cancer and CyberKnife with guest Jonathan Haas, MD
Manage episode 238995358 series 1441614
Despite advances in medicine, one in nine men in the United States will get prostate cancer in his lifetime, and it’s the second leading cause of cancer death among men in the U.S. On this episode, Jonathan Haas, MD, Chairman of the Department of Radiation Oncology at NYU Winthrop Hospital, joins me for an in-depth discussion about prostate cancer and treatment options, including CyberKnife, a non-invasive treatment that delivers targeted radiation to tumors and can reach deeply imbedded masses while minimizing damage to healthy tissue. CyberKnife provides hope to thousands of people with tumors once considered inoperable. Tune in and get the facts about prostate cancer and potentially life-saving treatments.
53 פרקים
Episode #50: Exploring Prostate Cancer and CyberKnife with guest Jonathan Haas, MD
TARA MARIE LIVE! – Mental, Emotional, Physical, Social, and Spiritual Heath
Manage episode 238995358 series 1441614
Despite advances in medicine, one in nine men in the United States will get prostate cancer in his lifetime, and it’s the second leading cause of cancer death among men in the U.S. On this episode, Jonathan Haas, MD, Chairman of the Department of Radiation Oncology at NYU Winthrop Hospital, joins me for an in-depth discussion about prostate cancer and treatment options, including CyberKnife, a non-invasive treatment that delivers targeted radiation to tumors and can reach deeply imbedded masses while minimizing damage to healthy tissue. CyberKnife provides hope to thousands of people with tumors once considered inoperable. Tune in and get the facts about prostate cancer and potentially life-saving treatments.
53 פרקים
כל הפרקים
×ברוכים הבאים אל Player FM!
Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.